Document Detail

Adherence to guidelines for respiratory syncytial virus immunoprophylaxis among infants with prematurity or chronic lung disease in three United States counties.
MedLine Citation:
PMID:  22760537     Owner:  NLM     Status:  MEDLINE    
Among infants with prematurity and/or chronic lung disease for whom respiratory syncytial virus immunoprophylaxis is recommended, we examined adherence in infants enrolled during healthcare visits for acute respiratory illness in 3 U.S. counties from 2001 to 2007. Immunoprophylaxis among infants who met national criteria for prophylaxis increased from 33% to 83% over the 6-year period; 17% (11/65) of infants who received immunoprophylaxis did not meet eligibility criteria.
Kecia N Carroll; Marie R Griffin; Kathryn M Edwards; Asad Ali; Yuwei Zhu; Marika K Iwane; Peter G Szilagyi; Mary A Staat; Timothy P Stevens; Caroline B Hall; John V Williams; Tina V Hartert
Related Documents :
22232627 - Optimal oxygen saturation in premature infants.
15891427 - Rapid viral testing in the evaluation of the febrile infant and child.
12592637 - Surgical infants on total parenteral nutrition have impaired cytokine responses to micr...
3028127 - Cytomegalovirus infection and bronchopulmonary dysplasia in premature infants.
23607607 - Customised birthweight models: do they increase identification of at-risk infants?
972787 - Riboflaven and bilirubin response during phototherapy.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Pediatric infectious disease journal     Volume:  31     ISSN:  1532-0987     ISO Abbreviation:  Pediatr. Infect. Dis. J.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-10-16     Completed Date:  2013-03-12     Revised Date:  2013-09-20    
Medline Journal Info:
Nlm Unique ID:  8701858     Medline TA:  Pediatr Infect Dis J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e229-31     Citation Subset:  IM    
Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antibodies, Monoclonal, Humanized / therapeutic use*
Antiviral Agents / therapeutic use
Chronic Disease
Infant, Newborn
Infant, Premature
Practice Guidelines as Topic*
Respiratory Syncytial Virus Infections / drug therapy*
Time Factors
United States / epidemiology
Grant Support
M01 RR000095/RR/NCRR NIH HHS; U01/IP000017/IP/NCIRD CDC HHS; U01/IP000022/IP/NCIRD CDC HHS; U01/IP000147/IP/NCIRD CDC HHS; U38/CCU217969//PHS HHS; U38/CCU417958//PHS HHS; U38/CCU522352//PHS HHS
Reg. No./Substance:
0/Antibodies, Monoclonal, Humanized; 0/Antiviral Agents; 0/palivizumab

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Preventing Coronary Artery Abnormalities: A Need for Earlier Diagnosis and Treatment of Kawasaki Dis...
Next Document:  Inhaled Nitric Oxide and Cerebral Malaria: Basis of a Strategy for Buying Time for Pharmacotherapy.